GMAB

Genmab A Stock Analysis

AI Rating

Good
  • Quality8/10
  • Growth↓ 4/10
  • Value↓ 3/10
Genmab A sales and earnings growth
GMAB Growth
Neutral
  • Revenue Y/Y↑ 24.32%
  • EPS Y/Y↓ -24.93%
  • FCF Y/Y↓ -22.42%
Genmab A gross and profit margin trends
GMAB Profitability
Great
  • Gross margin ↑ 93.30%
  • EPS margin↑ 21.00%
  • ROIC 5Y↑ 53.98%
Genmab A net debt vs free cash flow
GMAB Risk
Great
  • Debt / Equity↓ 0.9
  • Debt / FCF↓ 4.4
  • Interest coverage↓ 3.7

Genmab A stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks